StockTipsArenaBeta

BUY Divi's Laboratories Limited — Manas Jaiswal

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byManas JaiswalHorizon: NA (inferred Swing (≤2wk))25 Aug 2026via CNBC Awaaz.

Entry₹8,739.5Inferred
Target₹8,875
Total upside +1.55% (call closed)
Stop loss₹8,574-1.89% risk
Exit₹8,87526 Aug 2026, 9:45 am
Target hit+1.55%0.00%upside left
Follow Manas Jaiswal for new calls(30% target hit, 374 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 1 active Swing call on DIVISLABSee 147 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 26 Aug 2026
6 supporting1 neutral1 opposing
Supports the BUY call (6)

Divi’s, TVS Motors, Dixon See Bullish Signals: Analyst

NewsGoogle News·26 Aug · today

(opens in new tab)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·26 Aug · today

Divis Laboratories fixes July 24 record date for ₹30 dividend

NewsGoogle News·25 Aug · yesterday

(opens in new tab)

Divi's Laboratories recommends ₹30 dividend, outlines TDS compliance

NewsGoogle News·23 Aug · 2d ago

(opens in new tab)

1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced

NewsGoogle News·19 Aug · 6d ago

(opens in new tab)
Neutral / worth noting (1)

Nifty 24,500 पर फिसला, Divi's, MCX और Eternal पर रखें नज़र!

NewsGoogle News·12 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

Indian Pharma Stocks Face Volatility After US Tariff Proposal

NewsGoogle News·14 Aug · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Manas Jaiswal

Every call and its outcome